Table 1. Relationship between expression of stem cell markers and characteristics of 41 patients with ESCC.
| ALDH-1 | Bmi-1 | Nanog | |||||||
| Positive (n = 24) | Negative (n = 17) | P-value | Positive (n = 36) | Negative (n = 5) | P-value | Positive (n = 37) | Negative (n = 4) | P-value | |
| Age (years)1 | 55 (51, 64) | 51 (46, 59) | 0.255 | 54 (47, 62) | 56 (53, 61) | 0.282 | 55 (50, 62) | 46 (41, 50) | 0.033 |
| Gender, n (%)2 | 1.000 | 1.000 | 1.000 | ||||||
| Male | 23 (95.8) | 16 (94.1) | 34 (94.4) | 5 (100) | 35 (94.6) | 4 (100) | |||
| Female | 1 (4.2) | 1 (5.9) | 2 (5.6) | 0 (0.0) | 2 (5.4) | 0 (0.0) | |||
| Clinical stage, n(%)2 | 0.212 | 0.435 | 0.621 | ||||||
| II | 2 (8.3) | 5 (29.4) | 6 (16.7) | 1 (20.0) | 7 (18.9) | 0 (0.0) | |||
| III | 14 (58.3) | 9 (52.9) | 19 (52.8) | 4 (80.0) | 21 (56.8) | 2 (50.0) | |||
| IV | 8 (33.3) | 3 (17.6) | 11 (16.7) | 0 (0.0) | 9 (24.3) | 2 (50.0) | |||
Each number indicates median and interquartile range unless otherwise specified.
P-values are based on 1Mann-Whitney U test and 2Fisher's exact test.